Thursday, October 24, 2013 10:16:58 AM
Board of Directors Member
Mr. Devlin brings over 25 years of advertising and business development experience, having held various executive and creative positions in the beverage industry. Mr. Devlin oversaw the introduction of Diet Coke ® and TAB ® to the market for The Coca-Cola Company, and has a proven track record in new business development for advertising agencies having won over $300 million in new business for various agencies over the past five years. Previously in his career, Mr. Devlin served as Senior Vice President of New Business Development for Doner Advertising, where he placed accounts with organizations including The Coca-Cola Company, National Football League, Atari, Sirius SM Satellite Radio and Intel. Mr. Devlin was also previously a Senior Vice President at Lintas Worldwide Advertising, where he served as the head of television for accounts including The Coca-Cola Company, Heineken and General Motors. In this role, Devlin oversaw the launch of Coca-Cola's Diet Coke® brand, which became the third best-selling soft drink worldwide after just six months on the market.. Mr. Devlin's industry honors include 17 CLIO Awards; 16 Andy Awards for advertising excellence; 21 Telly Awards for outstanding commercials; four E e Media Awards; and a prestigious Gold Camera from the U.S. International Film Festival. His award-winning piece for Visa, Olympics is on permanent display at the Museum of Modern Art (MOMA) in New York.
MOJ$O Organics
Recent CMGO News
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 11/17/2023 02:59:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:02:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 08:05:48 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM